Cite
Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.
MLA
Brunelli, Matteo, et al. “Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.” Journal of Personalized Medicine, vol. 12, no. 5, Apr. 2022. EBSCOhost, https://doi.org/10.3390/jpm12050727.
APA
Brunelli, M., Martignoni, G., Malpeli, G., Volpe, A., Cima, L., Raspollini, M. R., Barbareschi, M., Tafuri, A., Masi, G., Barzon, L., Ammendola, S., Villanova, M., Cerruto, M. A., Milella, M., Buti, S., Bersanelli, M., Fornarini, G., Rebuzzi, S. E., Vellone, V. G., … Antonelli, A. (2022). Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study. Journal of Personalized Medicine, 12(5). https://doi.org/10.3390/jpm12050727
Chicago
Brunelli, Matteo, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Maria Rosaria Raspollini, Mattia Barbareschi, et al. 2022. “Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.” Journal of Personalized Medicine 12 (5). doi:10.3390/jpm12050727.